Aura Biosciences Inc (AURA)

Apr 14, 2026

Is Aura Biosciences (AURA) stock outpacing its medical peers this year? - MSN

Apr 14, 2026

Apr 14, 2026

Wall Street analysts predict a 201.49% upside in Aura Biosciences (AURA): Here's what you should know - MSN

Apr 14, 2026

Apr 10, 2026

Aura Biosciences, Inc. (AURA) just flashed golden cross signal: Do you buy? - MSN

Apr 10, 2026

Apr 10, 2026

Aura Biosciences, Inc. (AURA) Recently Triggered a Golden Cross Signal: Is It Time to Invest? - Bitget

Apr 10, 2026

Apr 10, 2026

Aura Biosciences, Inc. (AURA) Just Flashed Golden Cross Signal: Do You Buy? - Yahoo Finance

Apr 10, 2026

Apr 07, 2026

AURA Should I Buy - Intellectia AI

Apr 07, 2026

Apr 06, 2026

Is Aura Biosciences (AURA) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Apr 06, 2026

Apr 05, 2026

Quarterly Recap: Does Aura Biosciences Inc outperform in volatile markets2026 Dividend Review & Low Risk Investment Opportunities - baoquankhu1.vn

Apr 05, 2026

Apr 04, 2026

Aura Biosciences (NASDAQ:AURA) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat

Apr 04, 2026

Apr 03, 2026

Non Muscle Invasive Bladder Cancer Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Aura Biosciences, Protara Therapeutics, Vaxiion Therapeutics, Incyte Corp - Barchart.com

Apr 03, 2026

Apr 03, 2026

Non Muscle Invasive Bladder Cancer Pipeline 2026: Key - openPR.com

Apr 03, 2026

Apr 03, 2026

Research Analysts Offer Predictions for AURA FY2030 Earnings - Defense World

Apr 03, 2026

Apr 02, 2026

Wall Street experts forecast a potential 201.49% increase for Aura Biosciences (AURA): Key information you need to know - Bitget

Apr 02, 2026

Apr 02, 2026

Wall Street Analysts Predict a 201.49% Upside in Aura Biosciences (AURA): Here's What You Should Know - sharewise.com

Apr 02, 2026

Apr 02, 2026

FY2030 Earnings Forecast for AURA Issued By HC Wainwright - MarketBeat

Apr 02, 2026

Mar 31, 2026

H.C. Wainwright reiterates Aura Biosciences stock rating at buy By Investing.com - Investing.com Canada

Mar 31, 2026

Mar 31, 2026

H.C. Wainwright reiterates Aura Biosciences stock rating at buy - Investing.com

Mar 31, 2026

Mar 30, 2026

Aura Biosciences Reports 2025 Results, Advances Bel-Sar Pipeline - tipranks.com

Mar 30, 2026

Mar 30, 2026

Aura Biosciences (NASDAQ:AURA) Earns Buy Rating from HC Wainwright - MarketBeat

Mar 30, 2026

Mar 30, 2026

Aura Biosciences Reports 2025 Financial Results and Advances Phase 3 CoMpass Trial for Choroidal Melanoma - Minichart

Mar 30, 2026

Mar 30, 2026

Aura Biosciences 2025 Annual Report: Advancing Bel-sar for Ocular and Urologic Oncology with Late-Stage Clinical Development - Minichart

Mar 30, 2026

Mar 30, 2026

Aura Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 30, 2026

Mar 30, 2026

Aura Biosciences 10-K: $0 Revenue, $(106.2)M Net Loss - TradingView — Track All Markets

Mar 30, 2026

Mar 30, 2026

Aura Biosciences (NASDAQ:AURA) Issues Earnings Results - MarketBeat

Mar 30, 2026

Mar 30, 2026

Bel-sar pipeline data and cash risks in Aura Biosciences (NASDAQ: AURA) 10-K - Stock Titan

Mar 30, 2026

Mar 30, 2026

Aura Biosciences 2025 net loss widens as R&D costs rise - TradingView — Track All Markets

Mar 30, 2026

Mar 30, 2026

Aura Biosciences (NASDAQ: AURA) details 2025 loss, cash runway to Q1 2027 and bel-sar trial timelines - Stock Titan

Mar 30, 2026

Mar 30, 2026

BRIEF-Aura Biosciences FY Operating Expenses USD 112.791 Million - TradingView

Mar 30, 2026

Mar 30, 2026

Aura says eye melanoma Phase 3 enrollment now points to 2027 data - Stock Titan

Mar 30, 2026

Mar 29, 2026

Aura Biosciences, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com

Mar 29, 2026

Mar 28, 2026

(AURA) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Mar 28, 2026

Mar 27, 2026

Earnings Update: Is Aura Biosciences Inc exposed to currency risksForecast Cut & Advanced Technical Signal Analysis - baoquankhu1.vn

Mar 27, 2026

Mar 27, 2026

Aura Biosciences, Inc. (NASDAQ:AURA) Given Average Rating of "Hold" by Brokerages - MarketBeat

Mar 27, 2026

Mar 26, 2026

Notice of Successful Bidder Filed by Clearside Biomedical, Inc. - marketscreener.com

Mar 26, 2026

Mar 21, 2026

Is Aura Biosciences (AURA) outperforming other medical stocks this year? - MSN

Mar 21, 2026

Mar 21, 2026

What makes Aura Biosciences (AURA) a new buy stock - msn.com

Mar 21, 2026

Mar 20, 2026

Is Aura Biosciences (AURA) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Mar 20, 2026

Mar 17, 2026

Bear Alert: Is Aura Biosciences Inc stock undervalued right nowMarket Weekly Review & Technical Buy Zone Confirmation - baoquankhu1.vn

Mar 17, 2026

Mar 16, 2026

Aura Biosciences (AURA) to Release Earnings on Monday - MarketBeat

Mar 16, 2026

Mar 16, 2026

Aura Biosciences Posts Q2 Cash Surge - AOL.com

Mar 16, 2026

Mar 15, 2026

Latest AURA NewsAura Biosciences to Participate at the 11th... - Stock Titan

Mar 15, 2026

Mar 15, 2026

Aura Biosciences, Inc. (NASDAQ:AURA) Short Interest Update - MarketBeat

Mar 15, 2026

Mar 11, 2026

Aura Biosciences Eyes Phase 3 Enrollment Milestone, Reaffirms Q4 2027 Melanoma Data Timeline - Yahoo Finance

Mar 11, 2026

Mar 10, 2026

Why Lisata Therapeutics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Sahm

Mar 10, 2026

Mar 10, 2026

AURA: Phase 3 ocular oncology drug nears enrollment completion, with pivotal data expected in Q4 2027 - TradingView

Mar 10, 2026